HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Clinical trial NCT03354390 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03354390
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-20
- Primary completion
- 2023-10-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.